Paper41585441
Targeting IBD treatment: smart drug delivery systems for oral administration.
Xu J and 6 others. Mater Today Bio, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Targeting IBD treatment: smart drug delivery systems for oral administration. Papers, record 41585441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41585441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References206
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24184170 | Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. | J Crohns Colitis | 2014 | https://conductscience.org/library/papers/24184170 | PubMed |
| 2 | 35286854 | An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome. | Biomaterials | 2022 | https://conductscience.org/library/papers/35286854 | PubMed |
| 3 | 35863523 | SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation. | Gastroenterology | 2022 | https://conductscience.org/library/papers/35863523 | PubMed |
| 4 | 25543006 | Non-genetic engineering of cells for drug delivery and cell-based therapy. | Adv Drug Deliv Rev | 2015 | https://conductscience.org/library/papers/25543006 | PubMed |
| 5 | 34635910 | ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. | J Crohns Colitis | 2022 | https://conductscience.org/library/papers/34635910 | PubMed |
| 6 | 35285362 | Dual-targeted colon-based integrated micelle drug delivery system for treatment of ulcerative colitis. | J Drug Target | 2022 | https://conductscience.org/library/papers/35285362 | PubMed |
| 7 | 35101421 | What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented? | Gastroenterology | 2022 | https://conductscience.org/library/papers/35101421 | PubMed |
| 8 | 11768558 | The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. | Scand J Gastroenterol Suppl | 2001 | https://conductscience.org/library/papers/11768558 | PubMed |
| 9 | 35973472 | In situ hydrogel capturing nitric oxide microbubbles accelerates the healing of diabetic foot. | J Control Release | 2022 | https://conductscience.org/library/papers/35973472 | PubMed |
| 10 | 39633585 | Advances in colon-targeted drug technologies. | Curr Opin Gastroenterol | 2025 | https://conductscience.org/library/papers/39633585 | PubMed |
| 11 | 36958817 | Faecal metabolome and its determinants in inflammatory bowel disease. | Gut | 2023 | https://conductscience.org/library/papers/36958817 | PubMed |
| 12 | 28088460 | Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28088460 | PubMed |
| 13 | 35595052 | Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis. | Autoimmun Rev | 2022 | https://conductscience.org/library/papers/35595052 | PubMed |
| 14 | 36976334 | Comprehensive Analysis of the Physiological Characterization of Escherichia coli Nissle 1917. | Curr Microbiol | 2023 | https://conductscience.org/library/papers/36976334 | PubMed |
| 15 | 19348015 | pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. | Eur J Pharm Biopharm | 2009 | https://conductscience.org/library/papers/19348015 | PubMed |
| 16 | 37651187 | Theranostic gold-in-gold cage nanoparticles enable photothermal ablation and photoacoustic imaging in biofilm-associated infection models. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37651187 | PubMed |
| 17 | 29872293 | Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery. | Int J Nanomedicine | 2018 | https://conductscience.org/library/papers/29872293 | PubMed |
| 18 | 37733924 | Cyclosporine A-Encapsulated pH/ROS Dual-Responsive Nanoformulations for the Targeted Treatment of Colitis in Mice. | ACS Biomater Sci Eng | 2023 | https://conductscience.org/library/papers/37733924 | PubMed |
| 19 | 20393175 | Infliximab, azathioprine, or combination therapy for Crohn's disease. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20393175 | PubMed |
| 20 | 33107344 | Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. | Expert Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33107344 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42890836 | Release and Targeting Mechanism of Nanomedicine Delivery System in Inflammatory Bowel Disease. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42890836 | PubMed |
| 42856478 | Microbiome-aware oral drug delivery: excipient-microbiome interactions and nanocarrier design rules for predictable formulation performance. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42856478 | PubMed |
| 42806247 | Engineering Oral Nanoparticles: Navigating Biological Barriers in the Gastrointestinal Tract. | Pharm Res | 2026 | https://conductscience.org/library/papers/42806247 | PubMed |
| 42388373 | Oral hydrogel systems in lower gastrointestinal disorders: From disease-based therapy to microbiota-guided design. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42388373 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41585441
GET https://conductscience.org/api/papers/v1/41585441/references?page=2